The company said that its low-cost, high-throughput four-plex test could help to identify type 1 diabetes patients sooner and inform treatments to delay progression.
Having expanded access to quantitative hemoglobin variant testing in 40 countries, Hemex is now also setting its sights on the US and Europe.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback